Is fibroblast growth factor 23 the main culprit for cardiovascular disease in chronic kidney disease?

被引：0

作者：

Wagner, Carsten A. ^{[1
]}

Aliaga, Isabel Rubio ^{[1
]}

Egli-Spichtig, Daniela ^{[1
]}

机构：

[1] Univ Zurich, Inst Physiol, Zurich, Switzerland

来源：

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 2024年 / 326卷 / 04期

基金：

瑞士国家科学基金会;

关键词：

chronic kidney disease; fibroblast growth factor 23; heart; Klotho; phosphate;

D O I：

10.1152/ajprenal.00379.2023

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

引用

页码：F561 / F562

页数：2

共 10 条

[1] Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients [J].

Egli-Spichtig, Daniela ;

Hamid, Ahmad Kamal ;

Arroyo, Eva Maria Pastor ;

Ketteler, Markus ;

Wiecek, Andrzej ;

Rosenkranz, Alexander R. ;

Pasch, Andreas ;

Lorenz, Horst ;

Hellmann, Burkhard ;

Karus, Michael ;

Ammer, Richard ;

Rubio-Aliaga, Isabel ;

Wagner, Carsten A. .

CLINICAL KIDNEY JOURNAL, 2023, 16 (10) :1622-1633

[2] Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia [J].

Fuente, Rocio ;

Pastor-Arroyo, Eva-Maria ;

Gehring, Nicole ;

Carbajosa, Patricia Oro ;

Alonso-Duran, Laura ;

Zderic, Ivan ;

Tapia-Dean, James ;

Hamid, Ahmad Kamal ;

Bettoni, Carla ;

Santos, Fernando ;

Wagner, Carsten A. ;

Rubio-Aliaga, Isabel .

JOURNAL OF ENDOCRINOLOGY, 2023, 259 (01)

[3] Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation [J].

Goetz, Regina ;

Nakada, Yuji ;

Hu, Ming Chang ;

Kurosu, Hiroshi ;

Wang, Lei ;

Nakatani, Teruyo ;

Shi, Mingjun ;

Eliseenkova, Anna V. ;

Razzaque, Mohammed S. ;

Moe, Orson W. ;

Kuro-o, Makoto ;

Mohammadi, Moosa .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (01) :407-412

[4] Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy [J].

Grabner, Alexander ;

Amaral, Ansel P. ;

Schramm, Karla ;

Singh, Saurav ;

Sloan, Alexis ;

Yanucil, Christopher ;

Li, Jihe ;

Shehadeh, Lina A. ;

Hare, Joshua M. ;

David, Valentin ;

Martin, Aline ;

Fomoni, Alessia ;

Di Marco, Giovana Seno ;

Kentrup, Dominik ;

Reuter, Stefan ;

Mayer, Anna B. ;

Pavenstadt, Hermann ;

Stypmann, Joerg ;

Kuhn, Christian ;

Hille, Susanne ;

Frey, Norbert ;

Leifheit-Nestler, Maren ;

Richter, Beatrice ;

Haffner, Dieter ;

Abraham, Reimar ;

Bange, Johannes ;

Sperl, Bianca ;

Ullrich, Axel ;

Brand, Marcus ;

Wolf, Myles ;

Faul, Christian .

CELL METABOLISM, 2015, 22 (06) :1020-1032

[5] Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis [J].

Marthi, Amarnath ;

Donovan, Killian ;

Haynes, Richard ;

Wheeler, David C. ;

Baigent, Colin ;

Rooney, Christopher M. ;

Landray, Martin J. ;

Moe, Sharon M. ;

Yang, Jun ;

Holland, Lisa ;

di Giuseppe, Romina ;

Bouma-de Krijger, Annet ;

Mihaylova, Borislava ;

Herrington, William G. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (07) :2015-2027

[6] The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk [J].

Pastor-Arroyo, Eva-Maria ;

Gehring, Nicole ;

Krudewig, Christiane ;

Costantino, Sarah ;

Bettoni, Carla ;

Knopfel, Thomas ;

Sabrautzki, Sibylle ;

Lorenz-Depiereux, Bettina ;

Pastor, Johanne ;

Strom, Tim M. ;

de Angelis, Martin Hrabe ;

Camici, Giovanni G. ;

Paneni, Francesco ;

Wagner, Carsten A. ;

Rubio-Aliaga, Isabel .

KIDNEY INTERNATIONAL, 2018, 94 (01) :49-59

[7] A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY) [J].

Pergola, Pablo E. ;

Rosenbaum, David P. ;

Yang, Yang ;

Chertow, Glenn M. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (06) :1465-1473

[8] Phosphate intake, hyperphosphatemia, and kidney function [J].

Rubio-Aliaga, Isabel ;

Krapf, Reto .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2022, 474 (08) :935-947

[9] FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality [J].

Shalhoub, Victoria ;

Shatzen, Edward M. ;

Ward, Sabrina C. ;

Davis, James ;

Stevens, Jennitte ;

Bi, Vivian ;

Renshaw, Lisa ;

Hawkins, Nessa ;

Wang, Wei ;

Chen, Ching ;

Tsai, Mei-Mei ;

Cattley, Russell C. ;

Wronski, Thomas J. ;

Xia, Xuechen ;

Li, Xiaodong ;

Henley, Charles ;

Eschenberg, Michael ;

Richards, William G. .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (07) :2543-2553

[10]

Shi M, AmJ Physiol Renal Physiol.Inpress, DOI [10.1152/ajprenal.00298.2023.5, DOI 10.1152/AJPRENAL.00298.2023.5]

← 1 →